News

Willingness to volunteer for COVID-19 vaccine trials is high. But what trials are underway and who can be contacted for further information? To answer these questions and to match interested

Joint press release of the DZIF and the Heidelberg University Hospital

Malaria parasites of the species Plasmodium need the Anopheles mosquito to enter the human body. In turn, mosquito larvae need

Based on data involving more than 80,000 patients, an international research group has developed a programme that can predict the individual risk of tuberculosis. The results of this work were

The vaccine trial is on track. Last Friday, on 9 October, the first test subject was injected with the vaccine MVA-SARS-2-S against COVID-19. A total of six volunteers received the vector vaccine to

Healthcare-associated infections have been growing continuously for years, resulting in hundreds of thousands of avoidable deaths each year. The main culprit is bacteria that have become resistant to

The Paul-Ehrlich-Institut, the Federal Institute for Vaccines and Biomedicines, today approved the clinical trial of the MVA-SARS-2-S vaccine against COVID-19. The vector vaccine was developed by

An international team managed by scientists at the Research Center Borstel and the German Center for Infection Research (DZIF) have examined a new method for detecting resistant tuberculosis strains

Bonn, 6. August 2020. Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction – rather, the immune response is caught in a

Joint press release from Heidelberg University and the German Center for Infection Research (DZIF)

What started off as basic research 25 years ago has now led to a successfully approved drug: The

Who has overcome an infection with the virus without noticing, and how many people have already produced protective antibodies against the new coronavirus? Various antibody studies are now under way